Nimbus Raises Funds From Big Names | Chemical & Engineering News
Volume 89 Issue 27 | p. 12 | Concentrates
Issue Date: July 4, 2011

Nimbus Raises Funds From Big Names

Department: Business
Keywords: drug discovery, financing, venture capital

Nimbus Discovery, a computational drug discovery firm, has raised $24 million to help it advance its inflammatory and other disease candidates. New investors are GlaxoSmithKline’s venture fund SR One and Lilly Ventures. Existing investors Atlas Venture and Microsoft Chairman Bill Gates are also participating. In March, Nimbus got seed funding from Atlas, Gates, and Columbia University chemistry professor Richard Friesner, a founder of the chemical software firm Schrödinger, in which Gates has also invested. Nimbus was founded by Atlas and Schrödinger in 2009.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment